Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

ONCO

+ Watchlist+ Portfolio

Onconetix, Inc.

Regulated industryPhysical productsSells to businessesDevelopment stageTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$3.00
52-Week Range
$2.76 – $1,610.00
Market Cap
$2.58M
P/E (TTM)
0.00
EPS (TTM)
3103.90
Dividend Yield
0.00%
Advanced Metrics
Price/Book
—
PEG Ratio
—
Return on Equity
—
Return on Assets
-24.93%
Gross Margin
73.81%
Operating Margin
-1578.28%
Profit Margin
0.00%
Current Ratio
1.47
Debt/Equity
—
Total Debt
$105.07K
Free Cash Flow
$-19.31M
Revenue Growth
-66.10%
Earnings Growth
—
Enterprise Value
$-51.66K

Market Snapshot

About

Onconetix, Inc. develops oncology therapeutics focused on novel cancer treatments. The company works on targeted therapies and innovative drug candidates for various cancer types.